Accumulation of CTLA-4 expressing T lymphocytes in the germinal centres of human lymphoid tissues

Immunology

Volumn 90, Issue 2, 1997, Pages 265-271

  Castan, J ^a   Tenner Racz, K ^a   Racz, P ^a   Fleischer, B ^a   Broker B M ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR;

APOPTOSIS; ARTICLE; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TONSIL CELL;

EID: 0031026335     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00162.x     Document Type: Article

References (36)

1. SWAIN S.L. & RETH M. (1994) Lymphocytes: the ultimate computers? Curr Opin Immunol 6, 355.
2. BRUNET J.-F., DENIZOT F., LUCIANI M.-F. et al. (1987) A new member of the immunoglobulin superfamily- CTLA-4. Nature 328, 267.
3. DARIAVACH P., MATTÉI M.G., GOLSTEIN P. & LEFRANC M.-P. (1988) Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Europ J Immunol 18, 1901.
4. HARPER K., BALZANO C., ROUVIER E., MATTÉI M.G., LUCIANI M.-F. & GOLSTEIN P. (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147, 1037.
5. PEACH R.J., BAJORATH J., BRADY W. et al. (1994) Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med 180, 2049.
6. LINSLEY P.S., BRADY W., URNES M., GROSMAIRE L.S., DAMLE N.K. & LEDBETTER J.A. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 174, 561.
7. LINSLEY P.S., GREENE J.L., BRADY W., BAJORATH J., LEDBETTER J.A. & PEACH R. (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793.
8. KRUMMEL M.F. & ALLISON J.P. (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 182, 459.
9. LINSLEY P.S. (1995) Distinct roles for CD28 and cytotoxic T lymphocyte associated molecule-4 during T-cell activation? J Exp Med 182, 289.
10. ALLISON J.P. & KRUMMEL M.F. (1995) The yin and yang of T-cell costimulation. Science 270, 932.
11. MUELLER D.L., JENKINS M.K. & SCHWARTZ R.H. (1989) Clonal expansion versus functional inactivation: a costimulatory pathway determines the outcome of T cell receptor occupancy. Annu Rev Immunol 7, 445.
12. JUNE C.H., BLUESTONE J.A., NADLER L.M. & THOMPSON C.B. (1994) The B7 and CD28 receptor families. Immunol Today 15, 321.
13. FREEMAN G.J., LOMBARD D.B., GIMMI CD. et al. (1992) CTLA-4 and CD28 mRNAs are coexpressed in most activated T cells after activation: expression of CTLA-4 and CD28 messenger RNA does not correlate with the pattern of lymphokine production. J Immunol 149, 3795.
14. LINSLEY P.S., GREENE J.L., TAN P. et al. (1992) Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J Exp Med 176, 1595.
15. WALUNAS T.L., LENSCHOW D.J., BAKKER C.Y. et al. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405.
16. WATERHOUSE P., PENNINGER J.M., TIMMS E. et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985.
17. TIVOL E.A., BORRIELLO F., SCHWEITZER A.N., LYNCH W.P., BLUESTONE J. & SHARPE A.H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role for CTLA-4. Immunity 3, 541.
18. + T cells in vivo is dependent of CD28 costimulation and inhibited by CTLA-4. J Immunol 155, 1032.
19. SAYEGH M.H., AKALIN E., HANCOCK W.W. et al. (1995) CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 181, 1869.
20. KUCHROO V.K., DAS M.P., BROWN J.A. et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707.
21. BOUSSIOTIS V.A., GRIBBEN J.G., FREEMAN G.J. & NADLER L.M. (1994) Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr Opin Immunol 6, 797.
22. LEACH D.R., KRUMMEL M.F. & ALLISON J.P. (1996) Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734.
23. KUIPER H.M., BROUWER M., LINSLEY P. & VAN LIER R.A.W. (1995) Activated T cells can induce high levels of CTLA-4 expression on B cells. J Immunol 155, 1776.
24. VYTH-DREESE F.A., DELLEMIJN T.A.M., MAJOOR D. & DE JONG D. (1995) Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Europ J Immunol 25, 3023.
25. VERWILGHEN J., LOVIS R., DE BROER M. et al. (1994) Expression of functional B7 and CTLA-4 on rheumatoid synovial T cells. J Immunol 153, 1378.
26. GAVRIELI Y., SHERMAN Y. & BEN-SASSON S.A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119, 493.
27. POPPEMA S., VISSER L. & DE LEIJ L. (1983) Reactivity of presumed anti-natural killer cell antibody leu 7 with intrafollicular T lymphocytes. Clin Exp Immunol 54, 834.
28. BOUZAHZAH F., SUZUKI S., BOSSELOIR A., SIMAR L.J. & HEINEN E. (1995) T cells in contact with follicular dendritic cells. In: Follicular Dentritic Cells in Normal and Pathological Conditions, (ed. E. Heinen), pp. 79-96. Springer, New York.
29. GERDES J., LEMKE H., BAISCH H., WACKER H.-H., SCHWAB U. & STEIN H. (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133, 1710.
30. GRIBBEN J.G., FREEMAN G.J., BOUSSIOTIS V.A. et al. (1995) CTLA4 mediated antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 92, 811.
31. KELSOE G. (1996) Life and death in germinal centers (redux). Immunity 4, 107.
32. + cells with natural killer cell-related features, divergence from typical T helper cells. J Immunol 137, 2808.
33. CALLARD R.E., ARMITAGE R.J., FANSLOW W.C. & SPRIGGS M.K. (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14, 559.
34. FOY T.M., LAMAN J.D., LEDBETTER J.A., ARUFFO A., CLAASSEN E. & NOELLE R.J. (1994) gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 180, 157.
35. + T cells. J Exp Med 179, 819.
36. HAN S., HATHCOCK K., ZHENG B., KEPLER T.B., HODES R. & KELSOE G. (1995) Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J Immunol 155, 556.